Recombinant subunit West Nile virus vaccine for protections of human subjects

Details for Australian Patent Application No. 2010257162 (hide)

Owner Hawaii Biotech, Inc.

Inventors Coller, Beth-Ann; Pai, Vidya; WeeksLevy, Carolyn L.; Ogata, Steven A.

Agent Spruson & Ferguson

Pub. Number AU-A-2010257162

PCT Pub. Number WO2010/141084

Priority 61/182,754 31.05.09 US

Filing date 1 June 2010

Wipo publication date 9 December 2010

International Classifications

A61K 39/12 (2006.01) Medicinal preparations containing antigens or antibodies - Viral antigens

Event Publications

1 December 2011 PCT application entered the National Phase

  PCT publication WO2010/141084 Priority application(s): WO2010/141084

8 December 2011 Assignment before Grant

  Hawaii Biotech, Inc. The application has been assigned to Merck Sharp & Dohme Corp. 2011

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010257174-Continuously regulated precision pressure fluid delivery system

2010257159-Method and device for detecting and assessing reactive hyperemia using segmental plethysmography